Related Experiment Videos

Cytomegalovirus disease as a possible etiologic factor for early atherosclerosis

B Biocina1, I Husedzinović, Z Sutlić

  • 1Department of Cardiac Surgery, Clinic of Surgery, Clinical Hospital Dubrava, Zagreb, Croatia.

Collegium Antropologicum
|January 26, 2000
PubMed

Insights

Cytomegalovirus disease significantly worsens long-term survival after heart transplantation, increasing coronary atherosclerosis. Early cytomegalovirus infection without disease has a less severe impact on patient outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Orthotopic heart transplantation is a life-saving procedure.
  • Cytomegalovirus (CMV) infection is a common complication post-transplant.
  • The impact of CMV infection and disease on long-term heart transplant outcomes requires further elucidation.

Purpose of the Study:

  • To analyze the long-term survival of heart transplant recipients.
  • To determine the influence of cytomegalovirus infection and disease on survival.
  • To identify factors affecting post-transplant outcomes.

Main Methods:

  • Retrospective analysis of 284 heart transplant patients followed for at least five years.
  • Patients categorized into three groups: no CMV infection, CMV infection only, and CMV disease.
  • Survival analysis considered donor/recipient age and sex, rejection episodes, ischemic time, and pulmonary vascular resistance.

Main Results:

  • Recipient age was a significant factor influencing survival.
  • Patients with cytomegalovirus disease experienced significantly worse long-term survival compared to those with infection only or no infection.
  • Increased incidence of coronary atherosclerosis was identified as the cause of death in patients with prior CMV disease.

Conclusions:

  • Cytomegalovirus disease, not just infection, is a critical determinant of poor long-term survival in heart transplant recipients.
  • CMV disease is strongly associated with the development of fatal coronary atherosclerosis post-transplantation.
  • Understanding and managing CMV disease is crucial for improving long-term outcomes in heart transplant patients.

Related Concept Videos